Close Menu
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
  • Editorials
Facebook X (Twitter) Instagram
Facebook LinkedIn
Financial Market News
Subscribe Now
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
  • Editorials
Financial Market News
You are at:Home»Posts Tagged "Respiratory syncytial virus"

Merck says experimental RSV treatment protected infants in trial

By FinMar NewsOctober 18, 2024

The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021.Andrew Kelly | ReutersMerck on Thursday said its…

FDA approves GSK RSV vaccine for adults 50 to 59

By FinMar NewsJune 7, 2024

A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.Hannah Mckay | ReutersThe Food and Drug Administration on Friday expanded the approval of GSK’s respiratory…

Energy News

Energy Costs Divide Curry, Otis at Climate Forum | News

Brent, WTI, Saudi Arabia, Houthi

The Iran war is driving clean energy development. It’s not enough to help

Transport companies sound alarm on skyrocketing fuel prices amid Iran war

Banks News

The FE – Strong governance, supervision crucial to banking reforms

NBK launches ‘NBK Reach’ for Kuwaiti students in UK

Industry moves: Wellington-Altus adds Saint John advisor team

Bank of England holds interest rates – industry reaction

Real Estate News

Elvis Superfan Snaps Up Graceland-Inspired Home for $150K

SC law needs clarity on when apartments get a tax break

Law firm tees up class action linked to MRED-Compass deal

Is Cuba Trump’s next real estate project? : Code Switch : NPR

© 2026 finmar.news

Type above and press Enter to search. Press Esc to cancel.

Social Media Auto Publish Powered By : XYZScripts.com